<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01287910</url>
  </required_header>
  <id_info>
    <org_study_id>Amsterdam</org_study_id>
    <nct_id>NCT01287910</nct_id>
  </id_info>
  <brief_title>Transmyocardial Laser Revascularization and Cardiovascular Magnetic Resonance Imaging</brief_title>
  <acronym>Amsterdam</acronym>
  <official_title>Effect of Transmyocardial Laser Revascularization on Myocardial Perfusion and Left Ventricular Structure by Cardiovascular Magnetic Resonance Imaging and Dynamic Volumetric Computed Tomography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Piedmont Healthcare</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Piedmont Healthcare</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary goal of this study is to better understand how Transmyocardial Laser
      Revascularization (TMR) affects the functioning of the heart and, in turn, relieves angina in
      individuals with coronary heart disease using Magnetic Resonance (MR) images and Computed
      Tomography (CT) images in some patients.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Lack of patient population
  </why_stopped>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">August 2013</completion_date>
  <primary_completion_date type="Actual">August 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of coronary arteries with blood flow defects evaluated by magnetic resonance imaging (MRI) or computed tomography (CT)</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">2</enrollment>
  <condition>Angina</condition>
  <condition>Chest Pain</condition>
  <arm_group>
    <arm_group_label>All Patients</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>All patients undergo the same study procedures</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cardiac MRI</intervention_name>
    <description>Cardiac MRI within 30 days prior to TMR procedure and 6 months after TMR procedure.</description>
    <arm_group_label>All Patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female 18 years of age or over

          -  Patients with medically refractory, severe, class III or IV angina based on the
             Canadian Cardiovascular Society angina scale as determined by a physician

          -  Ejection fraction 25% or greater

          -  Patients with significant ischemia in the myocardium and who are NOT candidates for
             treatment by direct coronary revascularization methods (i.e., CABG or PCI)

          -  Ability and willingness to consent and Authorization for use of PHI

        Exclusion Criteria:

          -  Patient cannot undergo a surgical procedure or general anesthesia

          -  Patient not eligible for CMR study

          -  Severe unstable angina

          -  Q-wave MI within 3 weeks prior to TMR

          -  NQWMI within 2 weeks prior to TMR

          -  Decompensated heart failure (class III/IV) at the time of procedure

          -  Known increased bleeding risk

          -  Implanted pacemaker or defibrillator

          -  Clinically unstable arrhythmia

          -  Not able or willing to adhere to the study tests and procedures

          -  Inability or unwillingness to consent and Authorization for use of PHI
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Morris Brown, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Piedmont Heart Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Piedmont Heart Institute</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30309</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 31, 2011</study_first_submitted>
  <study_first_submitted_qc>February 1, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 2, 2011</study_first_posted>
  <last_update_submitted>September 4, 2013</last_update_submitted>
  <last_update_submitted_qc>September 4, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 5, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cardiac</keyword>
  <keyword>Angina</keyword>
  <keyword>Chest pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chest Pain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

